ORIGINAL RESEARCH article
Front. Med.
Sec. Hepatobiliary Diseases
Association Between ABO Blood Group System and Autoimmune liver disease
Provisionally accepted
- 1Xi'an Gaoxin Hospital, Xi'an, China
- 2Tangdou Hospital, Fourth Military Medical University, Xian, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Autoimmune liver disease (AILD) is a chronic inflammatory liver disease mediated by abnormal autoimmune response, and its pathogenesis has not been fully elucidated. Studies have shown that ABO blood is associated with autoimmune diseases, but the relationship between ABO blood groups and AILD has not been studied. The purpose of this study is to examine whether there is a correlation between ABO blood group and AILD. Methods: A retrospective cohort study was conducted on 114 AILD patients and 1167 healthy individuals from January 2019 to February 2024. Blood type was determined with the gel microcolumn assay. Chi-square test and logistic regression were performed to investigate the association between blood type and the risk of AILD. Results: Of 114 patients, 44 (38.60%) were diagnosed with autoimmune hepatitis (AIH), and 70 (61.40%) were diagnosed with primary biliary cholangitis (PBC). A significant difference was found between ABO blood groups and AILD patients. Compared with the controls, blood type A was more prevalent in the AILD group (OR, 1.784; P < 0.05), whereas blood type B was less (OR, 0.638; P < 0.05). Moreover, patients with PBC had a higher percentage of type A (OR, 2.656; P < 0.01) and a lower percentage of type B (OR, 0.514; P < 0.05). No significant difference was found in blood type O and AB (P > 0.05). Conclusion: Our findings suggest that ABO blood groups could potentially affect the presence of AILD.
Keywords: ABO blood type, Autoimmune liver disease, Autoimmune Hepatitis, Primary biliarycholangitis, Case control study
Received: 01 Sep 2025; Accepted: 31 Oct 2025.
Copyright: © 2025 Hong, Mu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Lin Wang, as04001@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.